Showing results (1161-1170 of 6,881) with videos related to
Sort By:
Pageof 689
Leukemia Research|August 14, 2010
The expansion of T-cells and hematopoietic progenitors as a result of overexpression of the lymphoblastic leukemia gene, Lyl1 can support leukemia formationGeorgi L Lukov, Lara Rossi, George P Souroullas, et al.Leukemia Research|June 15, 2010
The gold compound auranofin induces apoptosis of human multiple myeloma cells through both down-regulation of STAT3 and inhibition of NF-κB activityAya Nakaya, Morihiko Sagawa, Akihiro Muto, et al.Leukemia Research|August 10, 2010
Biologic activity of triptolide in t(8;21) acute myeloid leukemia cellsGui-Sheng Zhou, Zheng Hu, Hai-Tong Fang, et al.Leukemia Research|August 10, 2010
What are RBC-transfusion-dependence and -independence?R P Gale, G Barosi, T Barbui, et al.Leukemia Research|July 6, 2010
Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSFB Douglas Smith, Richard J Jones, Eunpi Cho, et al.Leukemia Research|July 15, 2010
The efficacy and safety of the low-thalidomide dose CTD (cyclophosphamide, thalidomide, dexamethasone) regimen in patients with multiple myeloma--a report by the Polish Myeloma Study GroupAnna Dmoszynska, Adam Walter-Croneck, Iwona Hus, et al.Leukemia Research|September 22, 2010
Role of Rho-ROCK signaling in MOLT4 cells metastasis induced by CCL25Li Zhang, Beibei Yu, Meng Hu, et al.Leukemia Research|June 24, 2008
Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AMLAlison R Walker, Rami S Komrokji, Jainulabdeen Ifthikharuddin, et al.Leukemia Research|June 25, 2008
Involvement of the TGF-beta and mTOR/p70S6Kinase pathways in the transformation process induced by v-ErbAS Gonin-Giraud, C Bresson-Mazet, O GandrillonLeukemia Research|September 5, 2007
CD117 (c-kit) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosisRégis Bataille, Catherine Pellat-Deceunynck, Nelly Robillard, et al.Pageof 689